ENTITY
SK Biopharmaceuticals

SK Biopharmaceuticals (326030 KS)

121
Analysis
Health CareSouth Korea
SK Biopharmaceuticals Co., Ltd. researches and develops new drugs. The Company develops and markets brain disorders treatment drugs, central nervous system disorders treatment drugs, and other products. SK Biopharmaceuticals markets its products worldwide.
more
Refresh
bullishSK Inc
21 May 2020 07:38

SK Holdings: Strong Momentum from SK Biopharm IPO & Updated SoTP Valuation Analysis

SK Holdings (034730 KS)'s share price has been on a tear lately. SK Holdings' share price is up 116% since 19 March, although it is still down 15%...

Logo
140 Views
Share
21 May 2020 02:49

SK Biopharmaceuticals IPO: Offering Terms & Issues for Consideration

This insight has two parts: 1. offering terms and 2. issues for consideration.Offering termsThis IPO would easily be this year's biggest from...

Logo
252 Views
Share
20 May 2020 15:25

SK Biopharm IPO Industry Analysis & Contract Details

In this insight, we provide further details on the SK Biopharmaceuticals (BIO SK) IPO, including the industry and competitive analysis. We have...

Logo
218 Views
Share
19 May 2020 22:44

SK Biopharm IPO Preview

SK Biopharmaceuticals (BIO SK) is getting ready to complete an IPO in the Korean stock market in June. The SK Biopharm will be one of the biggest...

Logo
228 Views
Share
x